CGI offers partners a broad range of capabilities, expertise and proprietary assets in kinase drug discovery and development. The Company is actively seeking partners in three areas:

• Strategic Alliances: Partnering of CGI's established drug discovery and development programs in autoimmune/allergic/inflammatory disease or oncology/angiogenesis, including gaining access to the Company's lead candidates, back-up compounds, and on-going efforts associated with these programs.

• Drug Discovery Collaborations: Partner can leverage CGI's expertise and capabilities in kinase assay development and chemistry, including access to proprietary kinase-focused compound libraries, to generate Preclinical and/or Clinical Development Candidates against one or more kinase targets.

Business development contact: